Higher BMI may surprisingly protect against death in critical illness, challenging decades of weight-loss advice. Research reveals complex biological mechanisms where metabolic reserves, mental health, and fitness matter more than the scale.
Peptide therapeutics—short amino acid chains bridging small molecules and antibodies—are revolutionizing drug design. Over 80 FDA-approved peptides treat diabetes, cancer, and rare diseases, with the $52B market projected to reach $82B by 2034. AI-driven design, oral delivery breakthroughs, and green manufacturing are enabling "undruggable" targets and personalized vaccines. Challenges include manufacturing scale, high costs, and regulatory complexity. The next decade will determine if peptid...
Loading featured articles...